Ukrain: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
''' | {{Short description|A semi-synthetic compound derived from the greater celandine plant}} | ||
{{Use dmy dates|date=October 2023}} | |||
'''Ukrain''' is a semi-synthetic compound that is derived from the plant ''[[Chelidonium majus]]'', commonly known as greater celandine. It has been the subject of various studies and controversies regarding its purported use in cancer treatment. | |||
==History== | ==History== | ||
Ukrain was first synthesized in the 1970s by Ukrainian chemist Vasyl Novytskyi. The compound is named after Ukraine, the country where it was developed. Initially, it was promoted as a potential treatment for cancer, but its efficacy and safety have been widely disputed. | |||
== | ==Chemical structure== | ||
[[File:Alleged_molecular_structure_of_ukrain.svg|thumb|right|Alleged molecular structure of Ukrain]] | |||
The chemical structure of Ukrain is based on alkaloids extracted from ''Chelidonium majus''. These alkaloids are then modified to create the semi-synthetic compound. The exact molecular structure has been a topic of debate, with some researchers questioning the validity of the proposed structure. | |||
== | ==Mechanism of action== | ||
The proposed mechanism of action for Ukrain involves the induction of apoptosis in cancer cells. It is suggested that Ukrain selectively targets cancer cells while sparing normal cells, although this claim lacks substantial scientific evidence. The compound is also believed to have immunomodulatory effects. | |||
== | ==Controversy and criticism== | ||
Ukrain has been the subject of significant controversy. Critics argue that there is insufficient clinical evidence to support its use as a cancer treatment. Several studies have failed to demonstrate its efficacy, and concerns have been raised about the quality of the research supporting its use. Regulatory agencies in various countries have not approved Ukrain for medical use, citing a lack of reliable data. | |||
== | ==Legal status== | ||
The legal status of Ukrain varies by country. In some regions, it is classified as an unapproved drug, while in others, it is available as a dietary supplement. The lack of regulatory approval in major markets such as the United States and the European Union has limited its availability. | |||
== | ==Related pages== | ||
* [[Chelidonium majus]] | |||
* [[Cancer treatment]] | |||
* [[Alternative medicine]] | |||
==References== | |||
{{Reflist}} | |||
[[Category:Alternative cancer treatments]] | |||
[[Category:Ukrainian inventions]] | |||
Revision as of 15:47, 9 February 2025
A semi-synthetic compound derived from the greater celandine plant
Ukrain is a semi-synthetic compound that is derived from the plant Chelidonium majus, commonly known as greater celandine. It has been the subject of various studies and controversies regarding its purported use in cancer treatment.
History
Ukrain was first synthesized in the 1970s by Ukrainian chemist Vasyl Novytskyi. The compound is named after Ukraine, the country where it was developed. Initially, it was promoted as a potential treatment for cancer, but its efficacy and safety have been widely disputed.
Chemical structure

The chemical structure of Ukrain is based on alkaloids extracted from Chelidonium majus. These alkaloids are then modified to create the semi-synthetic compound. The exact molecular structure has been a topic of debate, with some researchers questioning the validity of the proposed structure.
Mechanism of action
The proposed mechanism of action for Ukrain involves the induction of apoptosis in cancer cells. It is suggested that Ukrain selectively targets cancer cells while sparing normal cells, although this claim lacks substantial scientific evidence. The compound is also believed to have immunomodulatory effects.
Controversy and criticism
Ukrain has been the subject of significant controversy. Critics argue that there is insufficient clinical evidence to support its use as a cancer treatment. Several studies have failed to demonstrate its efficacy, and concerns have been raised about the quality of the research supporting its use. Regulatory agencies in various countries have not approved Ukrain for medical use, citing a lack of reliable data.
Legal status
The legal status of Ukrain varies by country. In some regions, it is classified as an unapproved drug, while in others, it is available as a dietary supplement. The lack of regulatory approval in major markets such as the United States and the European Union has limited its availability.
Related pages
References
<references group="" responsive="1"></references>